Management of Raynaud’s Phenomenon

John D. Pauling

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Cleveland Clinic Rheumatology

L. Calabrese, J. Gelfand, C. Oddis, J. Cush, A. Kavanaugh, R. Hajj-Ali

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

Imaging of Pituitary Lesions

Weill Cornell Medicine Courses and Meetings

C. Douglas Phillips

Myths and Misconceptions ANCA Associated Vasculitis

RheumNow

M. Putman

Rheumatology Update for the Generalist in 2024

McMaster University Department of Medicine

R. Mirza

Diagnosis of Giant Cell Arteritis

Houston Methodist DeBakey Heart and Vascular Center

S. To

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

Steroid Tapering in PMR: What's the Gold Standard?

RheumNow

A. Dua

How Does the Treatment of Behçet’s Disease Differ Based on Disease M…

Cleveland Clinic Rheumatology

G. Hatemi

GCA & Steroid Weaning

RheumNow

J. Cush

What’s Causing the Inflammatory Arthritis & Weight Loss? Why Did a R…

Cleveland Clinic Rheumatology Case Studies

A. Brown

70 y/o Male With Seropositive RA, ANCA Vasculitis, and ILD: Would An…

Keck School of Medicine of USC

C. Chen

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

Scalp and Skull Lesions in Babies and Children: What Are the Most Co…

Weill Cornell Medicine Courses and Meetings

C. Hoffman

PMR Mimics: PMR vs RA?

RheumNow

R. Spiera